Background Henoch-Schonlein purpura (HSP) is a systemic small vessel vasculitis that is mainly caused by IgA1-type immune complex deposition. Advanced oxidation protein products (AOPPs) are specific markers of protein oxidation.
Introduction
Henoch-Schonlein purpura (HSP) is a systemic small vessel vasculitis that is mainly caused by IgA1-type immune complex deposition. 1 It can affect many body organs such as the skin, joints, gastrointestinal tract, and kidneys. At present, it is believed that galactose-deficient IgA1 (Gd-IgA1) and the molec- levels in the course of the disease and negatively correlate with the rate of decline in renal function. It is speculated that the oxidative stress in children with IgA nephropathy may enhance the renal toxicity of Gd-IgA1.
In this study, serum AOPP and Gd-IgA1 levels and Cosmc mRNA expression in peripheral blood B lymphocytes in HSP patients with different clinical manifestations were studied, their correlations were analyzed, and their roles in the pathogenesis of HSP were explored. 
Materials and methods

Subjects
Detection of Cosmc mRNA expression in peripheral blood B lymphocytes
The peripheral blood mononuclear cells were separated according to the instructions for human peripheral blood lymphocyte separation. Two hundred microliters of PBS was added to prepare a cell suspension by pipetting repeatedly. Twenty microliters of mouse anti-human CD19-PE antibody was added to the cell suspension, mixed well, and incubated at room temperature for 15 minutes in the dark. After the unbound antibody was eluted, 1 ml PBS was added and mixed well by pipetting to prepare a cell suspension. The cells were sorted by flow cytometry and collected in tubes with RPMI1640 culture medium, which contained 10% fetal bovine serum. The suspension was centrifuged, washed, and the remaining precipitate of B lymphocytes was collected. The total RNA was extracted according to the Trizol instruction manual. The RNA purity and concentration were measured according to the 
Determination of the serum levels of AOPPs and Gd-IgA1
The measurements were obtained according to the instructions for the ELISA test kits.
Statistical analysis
All data were analyzed using SPSS 21.0 statistical analysis software with P < 0.05 as statistically significant. The data were tested for normality using the Shapiro-Wilk test, and the results were expressed as X AE S or MD (IQR), respectively, based on whether the assumption of normality was satisfied. For data that met the assumption of normality and variance homogeneity without modifying or after data conversion, one-way ANOVA single-factor variance analysis was used to compare in multiple groups, and LSD test was used for comparison between any two groups. Otherwise, Kruskal-Wallis H test for nonparametric tests was used. Spearman's rank correlation was used for correlation analysis, and the results were expressed as correlation coefficient r.
Results
The serum levels of AOPPs in HSP patients and controls did not satisfy the assumption of normality, and the results were expressed in MD (IQR). After square root conversion, the data met the assumption of normality (P > 0.1) with unequal variance (P < 0.1). The unequal variance t-test was used for comparison between two groups. The results show that the serum levels of AOPPs in HSP patients are significantly different from those in controls (t = 6.277, P = 0.000) ( Fig. 1 and 2) .
The serum levels of AOPPs in subgroups of HSP patients did not satisfy the assumption of normality, and the results were expressed in MD (IQR). After square root conversion, the data satisfied the assumption of normality and variance homogeneity (P > 0.1). One-way ANOVA single-factor variance analysis was used for comparison between multiple groups, and the LSD test was used for comparison between two groups. The results show that there is a significant difference between the serum levels of AOPPs in subgroups of HSP patients and controls (F = 23.068, P = 0.000 < 0.05), with the HSP patients having significantly higher AOPP levels than healthy controls. The renal subgroup has higher AOPP levels than the skin, joint, and abdominal subgroups (P < 0.05). The skin subgroup has lower AOPP levels than the other three subgroups (P < 0.05). There is no significant difference between the joint and the abdominal subgroups (P > 0.05) ( Fig. 2 and Table 3 ). 
Discussions
Oxidative stress refers to the imbalance between oxidation and antioxidation actions. Oxidized intermediates and ROS will be produced if oxidation action is stronger than antioxidation action.
During oxidative stress, protein is more prone to oxidative modification than carbohydrates and fats and accumulates in the body. Advanced oxidation protein products are the final oxidation Henoch-Schonlein purpura is a type of leukocytoclastic vasculitis. A large number of studies have shown that oxidative stress plays a key role in the pathogenesis. Nurcan Keskin et al. found that patients at the active stage had significantly higher AOPP levels than those at the remission stage of HSP and the controls. The mean AOPP levels of the patients with arthritis and/or arthralgia were significantly higher than those without joint involvement. 10 Our study also found that serum levels of AOPPs in HSP patients are significantly higher than those in healthy controls, but AOPP levels are more significantly elevated in the renal subgroup than the other three subgroups. Serum AOPP levels are positively correlated with serum Gd-IgA1 levels, and negatively correlated with the Cosmc mRNA expression in peripheral blood. These results suggest that AOPPs may play an important role in the development of HSP and that AOPPs and Gd-IgA1 act synergistically.
Advanced oxidation protein products (AOPPs) are not only the products of oxidative stress, they also induce monocytes and neutrophils to produce ROS and aggravate oxidative damage and chronic inflammation. AOPPs can also activate NF-jb transcription factor and induce nitric oxide synthase. 11, 12 The studies by Mahajan et al. 13, 14 have shown that the serum levels of NO and nitric oxide synthase activity in patients with HSP were significantly higher in the acute phase than those in remission or the control group. AOPPs can also activate monocyte NADPH oxidase, release ROS, promote P38 phosphorylation, and result in increased secretion of TNF-a. Meanwhile, the resulting ROS can cause cell damage. 15 Gd-IgA1 can activate the NF-jb transcription factor in monocytes. 16 These results suggest that NF-jb may be the common target of AOPPs and Gd-IgA1 in the pathogenesis of HSP.
In our previous study, we found that the Cosmc expression in HSP patients is abnormal and the level of Gd-IgA1 is increased. AOPPs may induce and exacerbate tissue damage by decreasing the expression of Cosmc mRNA, increasing the level of Gd-IgA1, and acting synergistically with them.
In this study, it was found that the serum levels of AOPPs in HSP patients and the HSP severity scores are positively correlated, suggesting that AOPPs can be used as one of the indicators for disease severity and prognosis during the course of disease. Additionally, it provides a theoretical basis for vitamin C, vitamin E, and other antioxidants to be used in the treatment of HSP (Fig. 6 ).
